Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
COMPLETE GENOMICS INC (GNOM)
|
Add to portfolio |
|
|
|
| Price: |
$19.13
| | Metrics |
| OS: |
34.5
|
M
| |
-245
|
% ROE
|
| Market cap: |
$660
|
M
| |
-269
|
% ROIC
|
|
Net cash:
|
$9.28
|
M
| |
$0.27
|
per share
|
|
EV:
|
$650
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($61.3)
|
M
| |
|
|
|
EBIT
|
($74.8)
|
M
| |
|
|
| EPS |
($2.42)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 19.3 | 9.4 | 0.6 | 23.6 | 10.3 |
| Revenue growth | 106.0% | 1407.1% | -97.4% | 129.3% | |
| Cost of goods sold | 28.3 | 19.9 | 5.0 | 4.2 | 1.9 |
| Gross profit | -9.0 | -10.5 | -4.4 | 19.4 | 8.4 |
| Gross margin | -46.3% | -111.9% | -707.9% | 82.1% | 81.6% |
| Sales and marketing | 13.6 | 6.1 | 1.8 | 1.0 | |
| Research and development | 32.7 | 21.7 | 22.4 | | |
| General and administrative | 14.0 | 9.3 | 5.0 | 3.2 | 1.9 |
| EBIT | -69.3 | -47.7 | -33.6 | -27.9 | -12.2 |
| EBIT margin | -358.2% | -507.5% | -5390.9% | -117.9% | -118.4% |
| Pre-tax income | -72.3 | -57.7 | -35.9 | -28.4 | -12.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -72.3 | -58.1 | -35.9 | -28.4 | -12.3 |
| Net margin | -374.0% | -618.7% | -5770.3% | -120.1% | -118.9% |
| |
| Diluted EPS | ($2.40) | ($13.60) | ($386.56) | | ($211.00) |
| Shares outstanding (diluted) | 30.1 | 4.3 | 0.1 | | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|